FDA.reportPublic FDA data

Application 205663

Type
ANDA
Sponsor
UNIQUE PHARM LABS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LITHIUM CARBONATELITHIUM CARBONATETABLET, EXTENDED RELEASE;ORAL450MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-3490Lithium CarbonateLithium CarbonateA-S Medication SolutionsANDACurrent
64980-278Lithium CarbonateLithium CarbonateRising Pharmaceuticals, Inc.ANDACurrent
64980-278Lithium CarbonateLithium CarbonateRising Pharmaceuticals, Inc.ANDACurrent
64980-278Lithium CarbonateLithium CarbonateRising Pharmaceuticals, Inc.ANDACurrent
70518-2086Lithium CarbonateLithium CarbonateREMEDYREPACK INC.ANDACurrent
70518-2086Lithium CarbonateLithium CarbonateREMEDYREPACK INC.ANDACurrent
70518-2086Lithium CarbonateLithium CarbonateREMEDYREPACK INC.ANDACurrent
70518-2086Lithium CarbonateLithium CarbonateREMEDYREPACK INC.ANDACurrent